Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases
Clinical trial NCT05466812 · UNKNOWN
Trial details
- NCT number
- NCT05466812
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2024-07-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.